FUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Clinical trial NCT03678428 · TERMINATED
Trial details
- NCT number
- NCT03678428
- Sponsor
- Sun Yat-sen University
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2022-10-31
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.